Vect-Horus

Vect Horus

Biotechnology, 51st BLVD, MARSEILLE, Colorado, 80011, United States, 11-50 Employees

vect-horus.com

  • twitter
  • LinkedIn

Who is VECT-HORUS

VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. V...

Read More

map
  • 51st BLVD, MARSEILLE , Colorado, 80011, United States Headquarters: 51st BLVD, MARSEILLE , Colorado, 80011, United States
  • 2005 Date Founded: 2005
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VECT-HORUS

Vect-Horus Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Vect-Horus

Answer: Vect-Horus's headquarters are located at 51st BLVD, MARSEILLE, Colorado, 80011, United States

Answer: Vect-Horus's official website is https://vect-horus.com

Answer: Vect-Horus's revenue is $1 Million to $5 Million

Answer: Vect-Horus's SIC: 2836

Answer: Vect-Horus's NAICS: 541714

Answer: Vect-Horus has 11-50 employees

Answer: Vect-Horus is in Biotechnology

Answer: Vect-Horus contact info: Phone number: Website: https://vect-horus.com

Answer: VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which limit access of therapeutic or imaging agents to their targets. The proof of concept of the technology has already been established in animal models using different vectorized molecules. Vect-Horus endorces a mixed business model, based on its proprietary VECTrans technology, both to make its technology platform available to pharmaceutical and biotechnology company partners and to develop an internal pipeline of products. Created in 2005, Vect-Horus is a spin-off of the Institute for Neurophysiopathology (INP, UMR7051, CNRS and Aix Marseille University), headed by Dr Michel Khrestchatisky, co-founder. Based in Marseille, France, the company has 35 employees, mostly in R&D, and develops academic collaborations with the CNRS, INSERM and CEA as well as industrial partnerships.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access